Listed on GrantGunner. Last checked 4 Nov 2026.
About this grant
Cancerfonden's Next Steps grant funds late-stage cancer research (TRL 6-9) to move promising results toward patient benefit, commercialization, or implementation in Swedish healthcare. It requires a consortium including a utilisation or commercialisation partner to support industry uptake or clinical implementation, and is open to research groups based in Sweden. Cancerfonden runs this call annually.